Skip to main content

Table 2 Incidence of adverse events

From: Combined use of dexmedetomidine and propofol in monitored anesthesia care: a randomized controlled study

Variable

P group (n = 28)

D group (n = 29)

M group (n = 30)

P value

Airway obstruction

1/2/3

15(53.6)/13(46.4)/0(0)

21(72.4)/8(27.6)/0(0)

29(96.7)/1(3.3)/0(0)*

<0.001

Hypoxia

12(42.9)

4 (13.8)*

1(3.3)*

0.001

Spontaneous movement

10 (35.7)

1 (3.4)*

0 (0)*

<0.001

Cough

5 (17.9)

3 (10.3)

1(3.3)

0.16

Nausea

0 (0)

0 (0)

0 (0)

1.00

Vomiting

0 (0)

0 (0)

0 (0)

1.00

Agitation

6 (21.4)

0 (0)*

0 (0)*

0.001

Bradycardia requiring atropine

1 (3.6)

8 (27.6)*

0 (0)

0.001

Hypotension requiring ephedrine

0 (0)

0 (0)

0 (0)

1.00

  1. Values are numbers of patients (%)
  2. *P < 0.05 compared to the P group, P < 0.05 compared to the D group